• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患者口服葡萄糖挑战后β和α细胞功能受损的特征:一项横断面研究。

Characterization of impaired beta and alpha cell function in response to an oral glucose challenge in cystic fibrosis: a cross-sectional study.

机构信息

Cystic Fibrosis Centre Copenhagen, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Centre for Physical Activity Research, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

出版信息

Front Endocrinol (Lausanne). 2023 Aug 31;14:1249876. doi: 10.3389/fendo.2023.1249876. eCollection 2023.

DOI:10.3389/fendo.2023.1249876
PMID:37720541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10501799/
Abstract

AIMS

The purpose of the study was to further elucidate the pathophysiology of cystic fibrosis (CF)-related diabetes (CFRD) and potential drivers of hypoglycaemia. Hence, we aimed to describe and compare beta cell function (insulin and proinsulin) and alpha cell function (glucagon) in relation to glucose tolerance in adults with CF and to study whether hypoglycaemia following oral glucose challenge may represent an early sign of islet cell impairment.

METHODS

Adults with CF (≥18 years) were included in a cross-sectional study using an extended (-10, -1, 10, 20, 30, 45, 60, 90, 120, 150, and 180 min) or a standard (-1, 30, 60, and 120 min) oral glucose tolerance test (OGTT). Participants were classified according to glucose tolerance status and hypoglycaemia was defined as 3-hour glucose <3.9 mmol/L in those with normal glucose tolerance (NGT) and early glucose intolerance (EGI).

RESULTS

Among 93 participants, 67 underwent an extended OGTT. In addition to worsening in insulin secretion, the progression to CFRD was associated with signs of beta cell stress, as the fasting proinsulin-to-insulin ratio incrementally increased (p-value for trend=0.013). The maximum proinsulin level (pmol/L) was positively associated with the nadir glucagon, as nadir glucagon increased 6.2% (95% confidence interval: 1.4-11.3%) for each unit increase in proinsulin. Those with hypoglycaemia had higher 60-min glucose, 120-min C-peptide, and 180-min glucagon levels (27.8% [11.3-46.7%], 42.9% [5.9-92.85%], and 80.3% [14.9-182.9%], respectively) and unaltered proinsulin-to-insulin ratio compared to those without hypoglycaemia.

CONCLUSIONS

The maximum proinsulin concentration was positively associated with nadir glucagon during the OGTT, suggesting that beta cell stress is associated with abnormal alpha cell function in adults with CF. In addition, hypoglycaemia seemed to be explained by a temporal mismatch between glucose and insulin levels rather than by an impaired glucagon response.

摘要

目的

本研究旨在进一步阐明囊性纤维化(CF)相关糖尿病(CFRD)的病理生理学和低血糖的潜在驱动因素。因此,我们旨在描述和比较 CF 成人中与葡萄糖耐量相关的胰岛β细胞功能(胰岛素和胰岛素原)和胰岛α细胞功能(胰高血糖素),并研究口服葡萄糖耐量试验(OGTT)后是否可能存在低血糖代表胰岛细胞损伤的早期迹象。

方法

本横断面研究纳入了≥18 岁的 CF 成人,采用延长(-10、-1、10、20、30、45、60、90、120、150 和 180 分钟)或标准(-1、30 和 60 分钟)OGTT。根据葡萄糖耐量状态对参与者进行分类,对于正常葡萄糖耐量(NGT)和早期葡萄糖耐量受损(EGI)者,定义低血糖为 3 小时血糖<3.9mmol/L。

结果

在 93 名参与者中,有 67 名进行了延长 OGTT。除了胰岛素分泌恶化外,向 CFRD 的进展与β细胞应激的迹象有关,因为空腹胰岛素原与胰岛素的比值逐渐增加(趋势检验的 p 值=0.013)。最大胰岛素原水平(pmol/L)与胰高血糖素的最低值呈正相关,因为胰高血糖素的最低值增加了 6.2%(95%置信区间:1.4-11.3%),而胰岛素原增加了一个单位。与无低血糖者相比,有低血糖者的 60 分钟血糖、120 分钟 C 肽和 180 分钟胰高血糖素水平更高(27.8%[11.3-46.7%]、42.9%[5.9-92.85%]和 80.3%[14.9-182.9%]),而胰岛素原与胰岛素的比值无差异。

结论

最大胰岛素原浓度与 OGTT 时的胰高血糖素最低值呈正相关,表明 CF 成人中β细胞应激与异常的α细胞功能有关。此外,低血糖似乎是由于葡萄糖和胰岛素水平之间的时间不匹配引起的,而不是由于胰高血糖素反应受损引起的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfb/10501799/1ad671a06841/fendo-14-1249876-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfb/10501799/639d0d15dc9f/fendo-14-1249876-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfb/10501799/56558da72397/fendo-14-1249876-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfb/10501799/1ad671a06841/fendo-14-1249876-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfb/10501799/639d0d15dc9f/fendo-14-1249876-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfb/10501799/56558da72397/fendo-14-1249876-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfb/10501799/1ad671a06841/fendo-14-1249876-g003.jpg

相似文献

1
Characterization of impaired beta and alpha cell function in response to an oral glucose challenge in cystic fibrosis: a cross-sectional study.囊性纤维化患者口服葡萄糖挑战后β和α细胞功能受损的特征:一项横断面研究。
Front Endocrinol (Lausanne). 2023 Aug 31;14:1249876. doi: 10.3389/fendo.2023.1249876. eCollection 2023.
2
Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.口服葡萄糖耐量试验后胰腺功能不全囊性纤维化患者出现低血糖和胰岛功能障碍。
J Clin Endocrinol Metab. 2020 Oct 1;105(10):3179-89. doi: 10.1210/clinem/dgaa448.
3
Glycaemic control in labour with diabetes: GILD, a scoping study.糖尿病产妇分娩期间的血糖控制:GILD,一项范围界定研究。
Health Technol Assess. 2025 Aug;29(41):1-150. doi: 10.3310/KHGD2761.
4
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Screening for cystic fibrosis-related diabetes: a systematic review.囊性纤维化相关性糖尿病的筛查:系统评价。
Health Technol Assess. 2012;16(24):iii-iv, 1-179. doi: 10.3310/hta16240.
7
Insulin and oral agents for managing cystic fibrosis-related diabetes.用于治疗囊性纤维化相关糖尿病的胰岛素和口服药物。
Cochrane Database Syst Rev. 2016 Apr 18;4:CD004730. doi: 10.1002/14651858.CD004730.pub4.
8
Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes.用于患有已确诊糖尿病/糖耐量受损或既往妊娠糖尿病且计划怀孕的女性,或患有孕前糖尿病的孕妇的口服抗糖尿病药物。
Cochrane Database Syst Rev. 2017 Oct 18;10(10):CD007724. doi: 10.1002/14651858.CD007724.pub3.
9
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.用于治疗肾移植受者中已存在的和新发糖尿病的降糖药物。
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2.
10
Changes in immunofluorescence staining during islet regeneration in a cystic fibrosis-related diabetes (CFRD) ferret model.囊性纤维化相关糖尿病(CFRD)雪貂模型中胰岛再生过程中免疫荧光染色的变化。
Islets. 2024 Dec 31;16(1):2436696. doi: 10.1080/19382014.2024.2436696. Epub 2024 Dec 6.

引用本文的文献

1
Identification of a vimentin-expressing α-cell phenotype in CF and normal pancreas.在囊性纤维化(CF)和正常胰腺中鉴定表达波形蛋白的α细胞表型。
J Endocrinol. 2025 Feb 17;264(3). doi: 10.1530/JOE-24-0190. Print 2025 Mar 1.

本文引用的文献

1
Brief overview: glucagon history and physiology.简要概述:胰高血糖素的历史和生理学。
J Endocrinol. 2023 Jul 11;258(2). doi: 10.1530/JOE-22-0224. Print 2023 Aug 1.
2
Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test.用于评估口服葡萄糖耐量试验中胰岛素介导的胰高血糖素抑制作用的胰高血糖素动力学数学模型。
Front Endocrinol (Lausanne). 2021 Mar 22;12:611147. doi: 10.3389/fendo.2021.611147. eCollection 2021.
3
Reflection on modern methods: demystifying robust standard errors for epidemiologists.
反思现代方法:为流行病学家揭开稳健标准误的神秘面纱。
Int J Epidemiol. 2021 Mar 3;50(1):346-351. doi: 10.1093/ije/dyaa260.
4
Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.口服葡萄糖耐量试验后胰腺功能不全囊性纤维化患者出现低血糖和胰岛功能障碍。
J Clin Endocrinol Metab. 2020 Oct 1;105(10):3179-89. doi: 10.1210/clinem/dgaa448.
5
Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis.成年囊性纤维化患者口服葡萄糖后低血糖的代偿反应受损。
Diabetologia. 2020 May;63(5):1055-1065. doi: 10.1007/s00125-020-05096-6. Epub 2020 Jan 29.
6
Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia.胰腺功能不全合并餐后低血糖的囊性纤维化中胰岛素失调。
J Cyst Fibros. 2020 Mar;19(2):310-315. doi: 10.1016/j.jcf.2019.07.006. Epub 2019 Aug 8.
7
Survival in a bad neighborhood: pancreatic islets in cystic fibrosis.在恶劣环境中生存:囊性纤维化中的胰岛
J Endocrinol. 2019 Feb 1. doi: 10.1530/JOE-18-0468.
8
β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL.β 细胞分泌缺陷存在于胰腺功能不全型囊性纤维化中,1 小时口服葡萄糖耐量试验血糖≥155mg/dL。
Pediatr Diabetes. 2018 Nov;19(7):1173-1182. doi: 10.1111/pedi.12700. Epub 2018 Jun 21.
9
Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.胰岛白细胞介素-1β免疫反应是囊性纤维化的早期特征,可能导致β细胞衰竭。
Diabetes Care. 2018 Apr;41(4):823-830. doi: 10.2337/dc17-1387. Epub 2018 Feb 1.
10
Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes.囊性纤维化患儿胰岛的结构异常可能导致与囊性纤维化相关的糖尿病。
Sci Rep. 2017 Dec 8;7(1):17231. doi: 10.1038/s41598-017-17404-z.